MIETHKE proGAV 2.0 XABO Instrucciones De Manejo página 22

| INSTRUCTIONS FOR USE
No liability, guarantee or warranty for safety and
functionality can be assumed if the product is
modified in any way other than described in this
document, if it is combined with products by
another manufacturer or if it is used in any way
other than for the intended purpose and the
intended use.
Christoph Miethke GmbH & Co. KG points out
that the reference to its trademark rights applies
solely to jurisdictions in which it has trademark
rights.
proGAV 2.0 XABO
proGAV 2.0 XABO is intended for shunting of
cerebrospinal fluid (CSF).
Implantation of a long-term implant for the
extraction of cerebrospinal fluid from the
CSF circulation and its shunting into the
peritoneum
Treatment of hydrocephalus, e.g. by alle-
viation of the clinical symptoms
Reducing the risk of infection with
gram-positive bacteria thanks to antibi-
otic-impregnated catheters
The following indications apply to proGAV 2.0
XABO:
Treatment of hydrocephalus
The following contraindications apply to pro-
GAV 2.0 XABO:
Infections in the implantation area
Pathological concentrations levels (e.g. of
blood components and/or protein) within
the cerebrospinal fluid
Intolerance to materials of the shunt sys-
tem
Hypersensitivity to rifampicin and/or clin-
damycin hydrochloride
22
proGAV 2.0 XABO
Patients who are treated with a CSF shunt
system on account of their clinical picture
In order to avoid risks due to false diagnoses,
incorrect treatments and delays, the product
must only be used by users with the following
qualifications:
Medical professionals, e. g. neurosur-
geons
Knowledge of mode of operation and
intended use of the product
Successful participation in product training
Professional healthcare facilities
Implantation under sterile operating the-
atre conditions
proGAV ® 2.0 XABO ®